BFEC
WST icon

Benjamin F. Edwards & Company’s West Pharmaceutical WST Stock Holding History

Benjamin F. Edwards & Company’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$450K Buy
1,366
+106
+8% +$37.5K 0.01% 715
2024
Q1 		$499K Buy
1,260
+43
+4% +$15.9K 0.01% 656
2023
Q4 		$429K Buy
+1,217
New +$431K 0.01% 675

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Benjamin F. Edwards & Company's WST Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its West Pharmaceutical (WST) stake by 8.4% in Q2 2024, buying an estimated $37.5K and bringing the position to 1,366 shares worth $450K. The position accounts for 0.01% of the portfolio, ranked #715.

Benjamin F. Edwards & Company first reported a position in WST in Q4 2023 and has held it in 3 quarters since. The position peaked at $499K in Q1 2024. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Benjamin F. Edwards & Company held 1,366 shares of West Pharmaceutical worth $450K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 106 West Pharmaceutical shares in Q2 2024, an estimated $37.5K.
  • West Pharmaceutical made up 0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #715 holding.
  • Benjamin F. Edwards & Company first reported a position in West Pharmaceutical in Q4 2023 and has held it in 3 quarters since.
  • Benjamin F. Edwards & Company's West Pharmaceutical position peaked at $499K in Q1 2024.
  • 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.